A new colon cancer study from Pfizer is revealing that a combination of medications can potentially cut the risk of death in ...

A person with Alzheimer’s disease or other dementia most likely will experience significant behavioral changes, including ...

Researchers in a new study found that the drug showed an ability to protect the brain in a certain way, which is a critical ...

The study, which was published in the journal Alzheimer’s & Dementia Translational Research & Clinical Interventions, looked ...

Joe Walsh is the first Alzheimer's patient to be treated with an experimental nasal spray designed to reduce inflammation in ...

Women are at the center of a health crisis. As of March 2024, the Alzheimer's Association reported 60 percent of individuals ...

Donanemab is only for use in the early stages of Alzheimer’s disease. And for now at least, it comes with a hefty price tag.

More than $300 million in grant money promised to UCI, UCLA, USC and dozens of other California institutions has been axed ...

The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...

Researchers propose a framework for using human-based organoids to advance personalized medicine and improve Alzheimer’s ...

HSV-1 infection may be linked to the risk for Alzheimer’s disease, but antiviral treatment may be protective, a large ...